AFMD240517C7500
- 0.06
- 0.000.00%
Affimed NV Newsroom
Affimed Announces Acceptance Of An Abstract On Preclinical Data Of Its Innate Cell Engager AFM28 At The EHA 2024 Congress
Treatment with AFM28 innate cell engager (ICE), designed to target CD123-positive cancer cells in patients with acute myeloid leukemia (AML), led to dose-dependent tumor growth control in a validated
Express News | Affimed Announces Acceptance of AFM24 Clinical Abstract For EGFR-wildtype (EGFRwt) Non-Small Cell Lung Cancer (NSCLC) At The 2024 Annual Meeting Of The American Society Of Clinical Oncology
Does Affimed N.V. (AFMD) Have the Potential to Rally 263.36% as Wall Street Analysts Expect?
Express News | Affirmed Shares Are Trading Higher After HC Wainwright Maintained a Buy Rating on the Stock and Raised Its Price Target From $5 to $10
Affimed N.V. (NASDAQ:AFMD) Q4 2023 Earnings Call Transcript
Express News | Cantor Fitzgerald Reiterates Overweight on Affimed
Affimed Price Target Raised to $5.00/Share From $1.00 by Stifel
Affimed Price Target Raised to $5.00/Share From $1.00 by Stifel
Affimed Is Maintained at Buy by HC Wainwright & Co.
Affimed Is Maintained at Buy by HC Wainwright & Co.
Express News | HC Wainwright & Co. Maintains Buy on Affimed, Raises Price Target to $10
Affimed Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 85.19% HC Wainwright & Co. $5 → $10 Maintains Buy 11/15/2023 -7.41% HC Wainwright & Co. → $5 Re
Earnings Call Summary | Affimed NV(AFMD.US) Q4 2023 Earnings Conference
The following is a summary of the Affimed N.V. (AFMD) Q4 2023 Earnings Call Transcript:Financial Performance:Affimed ended the year 2023 with a reduced cash equivalents and investments of €72 million
Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M Estimate
Affimed Q4 EPS $(1.50) Beats $(1.67) Estimate, Sales $444.55K Miss $1.70M Estimate
Express News | Affimed FY EPS €(7.09) Down From €(6.04) YoY, Sales €8.91M Down From €41.35M YoY; Cash, Cash Equivalents And Investments Of €72M Provide Cash Runway Into 2H 2025
Affimed GAAP EPS of -€7.09, Revenue of €8.28M
Affimed 2023 Rev EUR8.3M >AFMD
Affimed 2023 Rev EUR8.3M >AFMD
Earnings Scheduled For March 28, 2024
Companies Reporting Before The Bell • Universal Stainless (NASDAQ:USAP) is expected to report quarterly earnings at $0.32 per share on revenue of $78.65 million. • Shimmick (NASDAQ:SHIM) is estimated
A Preview Of Affimed's Earnings
A Preview Of Affimed's Earnings
Notable Earnings Before Thursday's Open
Affimed N.V. (AFMD) Upgraded to Buy: Here's What You Should Know
Affimed N.V., Hutchmed, Annexon Among Healthcare Movers